Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 11 de 11
Filter
Add more filters










Publication year range
1.
Opt Lett ; 48(21): 5651-5654, 2023 Nov 01.
Article in English | MEDLINE | ID: mdl-37910725

ABSTRACT

This article proposes a new, to the best of our knowledge, separate absorption and multiplication (SAM) APD based on GaN/ß-Ga2O3 heterojunction with high gains. The proposed APD achieved a high gain of 1.93 × 104. We further optimized the electric field distribution by simulating different doping concentrations and thicknesses of the transition region, resulting in the higher avalanche gain of the device. Furthermore, we designed a GaN/ß-Ga2O3 heterojunction instead of the single Ga2O3 homogeneous layer as the multiplication region. Owing to the higher hole ionization coefficient, the device offers up to a 120% improvement in avalanche gain reach to 4.24 × 104. We subsequently clearly elaborated on the working principle and gain mechanism of GaN/ß-Ga2O3 SAM APD. The proposed structure is anticipated to provide significant guidance for ultraweak ultraviolet light detection.

2.
ACS Appl Mater Interfaces ; 15(39): 46493-46503, 2023 Oct 04.
Article in English | MEDLINE | ID: mdl-37729066

ABSTRACT

Surface potential is rarely investigated as an independent factor in influencing tissue regeneration on the metal surface. In this work, the surface potential on the titanium (Ti) surface was designed to be tailored and adjusted independently, which arises from the ferroelectricity and piezoelectricity of poled poly(vinylidene fluoride-trifluoroethylene) (PVTF). Notably, it is found that such controllable surface potential on the metal surface significantly promotes osteogenic differentiation of bone marrow mesenchymal stem cells (BMSCs) in vitro as well as bone regeneration in vivo. In addition, the intracellular calcium ion (Ca2+) concentration measurement further proves that such controllable surface potential on the metal surface could activate the transmembrane calcium channels and allow the influx of extracellular Ca2+ into the cytoplasm. That might be the reason for improved osteogenic differentiation of BMSCs and bone regeneration. These findings reveal the potential of the metal surface with improved bioactivity for stimulation of osteogenesis and show great prospects for fabricable implantable medical devices with adjustable surface potential.

3.
Small ; 18(39): e2203680, 2022 09.
Article in English | MEDLINE | ID: mdl-36031402

ABSTRACT

Precise timing of macrophage polarization plays a pivotal role in immunomodulation of tissue regeneration, yet most studies mainly focus on M2 macrophages for their anti-inflammatory and regenerative effects while the essential proinflammatory role of the M1 phenotype on the early inflammation stage is largely underestimated. Herein, a superparamagnetic hydrogel capable of timely controlling macrophage polarization is constructed by grafting superparamagnetic nanoparticles on collagen nanofibers. The magnetic responsive hydrogel network enables efficient polarization of encapsulated macrophage to the M2 phenotype through the podosome/Rho/ROCK mechanical pathway in response to static magnetic field (MF) as needed. Taking advantage of remote accessibility of magnetic field together with the superparamagnetic hydrogels, a temporal engineered M1 to M2 transition course preserving the essential role of M1 at the early stage of tissue healing, as well as enhancing the prohealing effect of M2 at the middle/late stages is established via delayed MF switch. Such precise timing of macrophage polarization matching the regenerative process of injured tissue eventually leads to optimized immunomodulatory bone healing in vivo. Overall, this study offers a remotely time-scheduled approach for macrophage polarization, which enables precise manipulation of inflammation progression during tissue healing.


Subject(s)
Bone Regeneration , Macrophages , Collagen/metabolism , Humans , Hydrogels/pharmacology , Immunomodulation , Inflammation/metabolism , Macrophages/metabolism , Phenotype
4.
J Nanobiotechnology ; 19(1): 207, 2021 Jul 12.
Article in English | MEDLINE | ID: mdl-34247649

ABSTRACT

Metal ions have been identified as important bone metabolism regulators and widely used in the field of bone tissue engineering, however their exact role during bone regeneration remains unclear. Herein, the aim of study was to comprehensively explore the interactions between osteoinductive and osteo-immunomodulatory properties of these metal ions. In particular, the osteoinductive role of zinc ions (Zn2+), as well as its interactions with local immune microenvironment during bone healing process, was investigated in this study using a sustained Zn2+ delivery system incorporating Zn2+ into ß-tricalcium phosphate/poly(L-lactic acid) (TCP/PLLA) scaffolds. The presence of Zn2+ largely enhanced osteogenic differentiation of periosteum-derived progenitor cells (PDPCs), which was coincident with increased transition from M1 to M2 macrophages (M[Formula: see text]s). We further confirmed that induction of M2 polarization by Zn2+ was realized via PI3K/Akt/mTOR pathway, whereas marker molecules on this pathway were strictly regulated by the addition of Zn2+. Synergically, this favorable immunomodulatory effect of Zn2+ further improved the osteogenic differentiation of PDPCs induced by Zn2+ in vitro. Consistently, the spontaneous osteogenesis and pro-healing osteoimmunomodulation of the scaffolds were thoroughly identified in vivo using a rat air pouch model and a calvarial critical-size defect model. Taken together, Zn2+-releasing bioactive ceramics could be ideal scaffolds in bone tissue engineering due to their reciprocal interactions between osteoinductive and immunomodulatory characteristics. Clarification of this synergic role of Zn2+ during osteogenesis could pave the way to develop more sophisticated metal-ion based orthopedic therapeutic strategies.


Subject(s)
Bone Regeneration/drug effects , Immunomodulation/drug effects , Osteogenesis/drug effects , Zinc/chemistry , Zinc/pharmacology , Animals , Bone and Bones/pathology , Calcium Phosphates , Cell Differentiation/drug effects , Cell Proliferation/drug effects , Ceramics , Drug Liberation , Female , Male , Mice , Phosphatidylinositol 3-Kinases/metabolism , Polyesters , RAW 264.7 Cells , Rats , Rats, Sprague-Dawley , Stem Cells , Tissue Engineering , Tissue Scaffolds
5.
Arch Biochem Biophys ; 688: 108406, 2020 07 30.
Article in English | MEDLINE | ID: mdl-32417187

ABSTRACT

Increasing evidence indicates that aberrantly expressed microRNAs play a role in tumorigenesis and progression of gastric cancer. Recently, a novel cancer-related microRNA, miR-621, was found to be involved in cancer pathogenesis. However, the precise molecular mechanisms underlying the oncogenic activity of miR-621 remain unclear and require further investigation. In the current study, we demonstrate that miR-621 expression is downregulated in gastric cancer tissues and cell lines, and its reduction is associated with malignant clinical features including tumor size, lymph node metastasis, tumor-node-metastasis stage and poor prognosis. Functional studies involving gain- and loss-of-function experiments revealed that miR-621 represses cell viability, colony formation, cell cycle progression and proliferation in vitro, and miR-621 overexpression inhibited tumor growth in a gastric cancer xenograft model. SYF2 was identified as a direct target gene of miR-621 in gastric cancer. MiR-621 directly interacts with the SYF2 3'-UTR and post-transcriptionally repressed SYF2 expression in gastric cancer cells. SYF2 was significantly overexpressed in gastric cancer tissues and negatively correlated with miR-621 expression. Moreover, inhibition of SYF2 expression reversed the effects of miR-621 loss in gastric cancer cells. SYF2 overexpression was similar to that induced by miR-621 loss in gastric cancer. Taken together, these studies suggest that miR-621 may be a viable therapeutic target in gastric cancer.


Subject(s)
Cell Proliferation/physiology , MicroRNAs/metabolism , RNA-Binding Proteins/metabolism , Stomach Neoplasms/physiopathology , Animals , Cell Cycle/physiology , Cell Line, Tumor , Cyclin D1/metabolism , Down-Regulation , Gene Expression Regulation, Neoplastic/physiology , Humans , Male , Mice, Inbred BALB C , Prognosis , Stomach Neoplasms/diagnosis , Up-Regulation
6.
Life Sci ; 243: 117270, 2020 Feb 15.
Article in English | MEDLINE | ID: mdl-31923421

ABSTRACT

AIMS: The purpose of this study is to investigate the effect of PP2A on the progression of AS and the special molecular mechanism. MAIN METHODS: The expression of PP2A in Human umbilical vein endothelial cells (HUVECs) induced by different concentrations of Ox-LDL was measured by RT-PCR and Western blot. The binding activity of PP2A and LOX-1 was determined by CoIP assay. Western blot was used to measure the protein expression of VCAM-1, ICAM-1 and MCP-1. KEY FINDING: The results revealed that the expression of PP2A was decreased with the increase of Ox-LDL concentration in HUVECs. Overexpression of PP2A alleviated Ox-LDL-induced dysfunction and inflammatory response in HUVECs. The results of Co-immunoprecipitation (CoIP) showed that PP2A had direct effect on LOX-1, and PP2A inhibited the expression of LOX-1. In addition, overexpression of LOX-1 reversed the inhibitory effect of PP2A on Ox-LDL-induced dysfunction and inflammatory response in HUVECs. What is more, PP2A inhibited LOX-1/ROS/MAPK axis. SIGNIFICANCE: it suggests that PP2A alleviates Ox-LDL-induced dysfunction and inflammatory response of HUVECs potentially by regulating the LOX-1/ROS/MAPK axis,which suggests that PP2A has anti-inflammatory effect during the formation of as, and the molecular therapy of PP2A provides a theoretical basis.


Subject(s)
Endothelium, Vascular/drug effects , Lipoproteins, LDL/pharmacology , Lipoxygenase/metabolism , MAP Kinase Signaling System , Protein Phosphatase 2/metabolism , Reactive Oxygen Species/metabolism , Dose-Response Relationship, Drug , Endothelium, Vascular/metabolism , Endothelium, Vascular/physiopathology , Human Umbilical Vein Endothelial Cells , Humans , Inflammation/prevention & control , Lipoproteins, LDL/administration & dosage
7.
Mediators Inflamm ; 2020: 8292173, 2020.
Article in English | MEDLINE | ID: mdl-33456372

ABSTRACT

Vestigial-like 4 (VGLL4) has been found to have multiple functions in tumor development; however, its role in cardiovascular disease is unknown. The aim of this study was to investigate the effect of VGLL4 on the dysfunction and inflammatory response of Ox-LDL-induced human umbilical vein endothelial cells (HUVECs) and its mechanism, so as to provide a new theoretical basis for the diagnosis and treatment of atherosclerosis. In the present study, the protective activity of VGLL4 inhibiting Ox-LDL-induced apoptosis, oxidative stress, inflammation, and injury as well as its molecular mechanisms was examined using human umbilical vein endothelial cells (HUVECs). The results showed that the expression of VGLL4 was decreased with the increase of Ox-LDL concentration in HUVECs. In addition, the functional study found that VGLL4 overexpression alleviated Ox-LDL-induced oxidative stress, inflammation, and dysfunction and inhibited apoptosis. Further research found that VGLL4 regulated Hippo-YAP/TEAD1 signaling pathway, and the Hippo-YAP/TEAD1 signaling pathway was involved in the protective mechanism of VGLL4 on HUVECs. In conclusion, it suggests that VGLL4 protects against oxidized-LDL-induced endothelial cell dysfunction by activating the Hippo-YAP/TEAD1 signaling pathway.


Subject(s)
Adaptor Proteins, Signal Transducing/metabolism , DNA-Binding Proteins/metabolism , Endothelial Cells/metabolism , Lipoproteins, LDL/metabolism , Nuclear Proteins/metabolism , Protein Serine-Threonine Kinases/metabolism , Transcription Factors/metabolism , Adenosine Triphosphate/metabolism , Apoptosis , Atherosclerosis , Cell Survival/drug effects , Hippo Signaling Pathway , Human Umbilical Vein Endothelial Cells , Humans , Inflammation , Oxidative Stress , Protective Agents/pharmacology , Reactive Oxygen Species/metabolism , Signal Transduction , TEA Domain Transcription Factors , YAP-Signaling Proteins
8.
Life Sci ; 239: 116874, 2019 Dec 15.
Article in English | MEDLINE | ID: mdl-31521690

ABSTRACT

Atherosclerosis (AS) is a chronic inflammatory disease that results from Oxidized low-density lipoprotein (Ox-LDL) induced endothelial dysfunction. Cytoplasmic polyadenylation element binding protein 1 (CPEB1) is closely related to the development of epithelial cells, but the role of CPEB1 in AS remains unknown. The RNA and protein levels of CPEB1 expression are increased by Ox-LDL exposure, which is abrogated by c-Jun amino-terminal kinase (JNK) inhibitor SP600125. CPEB1 small interfering RNA (siRNA) suppressed the oxidative stress, inflammation, and apoptosis. Furthermore, CPEB1 siRNA enhanced the sirtuin 1 (SIRT1) transcription levels in Ox-LDL-treated HUVECs. Co-Immunoprecipitation (Co-IP) assay showed that CPEB1 siRNA declined the ubiquitination of SIRT1, and SIRT1 siRNA enhanced the Lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1), which were decreased by CPEB1 siRNA. In addition, LOX-1 and SIRT1 attenuated the protection of SIRT1 siRNA on Ox-LDL-induced oxidative stress. Therefore, our study revealed that CPEB1 depletion might play an anti-inflammatory and antiapoptotic role in Ox-LDL-induced apoptosis and inflammation though SIRT1/LOX-1 signalling pathway.


Subject(s)
Scavenger Receptors, Class E/metabolism , Sirtuin 1/metabolism , Transcription Factors/deficiency , mRNA Cleavage and Polyadenylation Factors/deficiency , Apoptosis/physiology , Atherosclerosis/metabolism , Atherosclerosis/physiopathology , Endothelium/metabolism , Human Umbilical Vein Endothelial Cells/metabolism , Humans , Inflammation/metabolism , Lipoproteins, LDL/metabolism , Oxidative Stress/drug effects , Signal Transduction , Transcription Factors/metabolism , mRNA Cleavage and Polyadenylation Factors/metabolism
9.
Sensors (Basel) ; 18(12)2018 Dec 02.
Article in English | MEDLINE | ID: mdl-30513845

ABSTRACT

Fibre-reinforced polymer (FRP) is used widely in concrete structures owing to its noncorrosive, light-weight, nonmagnetic, and high tensile-strength properties. However, the FRP-reinforced concrete flexural member exhibits low ductility owing to the linear⁻elastic property of FRP reinforcement. Hybrid steel-FRP-reinforced concrete members exhibit good strength and ductility under flexure owing to the inelastic deformation of steel reinforcement. The existing investigations have focused on the mechanical behaviours of the hybrid steel-FRP-reinforced flexural members. Only few studies have been reported on the members under combined flexural and compression loads, such as columns, owing to the poor compressive behaviour of FRP bars. We herein propose a new type of hybrid steel-FRP-reinforced concrete-engineered cementitious composite (ECC) composite column with ECC applied to the plastic hinge region and tested it under reversed cyclic loading. The hybrid steel-FRP-reinforced concrete column was also tested for comparison. The influence of matrix type in the plastic hinge region on the failure mode, crack pattern, ultimate strength, ductility, and energy dissipation capacity, of the columns were evaluated systematically. We found that the substitution of concrete with ECC in the plastic hinge zone can prevent the local buckling of FRP bars efficiently, and subsequently improve the strength and ductility of the column substantially.

10.
Cell Physiol Biochem ; 45(4): 1581-1589, 2018.
Article in English | MEDLINE | ID: mdl-29482191

ABSTRACT

BACKGROUND/AIMS: MicroRNAs (miRNAs) play an essential role in the tumorigenesis of osteosarcoma (OS). However, the effects of miR-1248 on chemo-resistant potential of OS have not been studied. Here, we addressed this question. METHODS: The levels of miR-1248 and apoptotic protein angiotensin II type 1 receptor (AGTR1) in OS specimens were examined by RT-qPCR and Western blotting, respectively. The relationship between miR-1248 and AGTR1 was determined by analysis of Spearman's Rank Correlation Coefficients. The patient survival was determined with Kaplan-Meier curves. Bioinformatics analyses were done to predict microRNAs (miRNAs) that target AGTR1. The functional binding of miRNAs to AGTR1 mRNA was examined by a dual luciferase reporter assay. Cell viability was determined by an CCK-8 assay. Apoptosis was determined by a fluorescence-based apoptosis assay. RESULTS: The levels of miR-1248 were significantly elevated while the levels of AGTR1 were significantly decreased in OS specimens than in paired adjacent normal tissue. The levels of miR-1248 were negatively correlated to the levels of AGTR1. Moreover, the patients with high miR-1248 levels had poorer survival than those with low MiR-1248 levels, and the patients with low AGTR1 levels had poorer survival than those with high AGTR1 levels. MiR-1248 inhibited protein translation of AGTR1, through binding to the 3'-UTR of the AGTR1 mRNA. The AGTR1-mediated cell apoptosis was suppressed by overexpressing miR-1248, and was augmented by depleting miR-1248. CONCLUSION: Increased miR-1248 expression in OS may inhibit AGTR1-mediated cancer cell death in chemotherapy. The outcome of chemotherapy may be improved by the suppression of miR-1248 in OS cells.


Subject(s)
Apoptosis , Bone Neoplasms/pathology , Osteosarcoma/pathology , Receptor, Angiotensin, Type 1/metabolism , Aged , Animals , Apoptosis/drug effects , Base Sequence , Bone Neoplasms/metabolism , Bone Neoplasms/mortality , Cell Line, Tumor , Cell Survival/drug effects , Disease Progression , Down-Regulation , Female , Fluorouracil/toxicity , Humans , Kaplan-Meier Estimate , Male , Mice , Mice, Inbred NOD , Mice, SCID , MicroRNAs/chemistry , MicroRNAs/genetics , MicroRNAs/metabolism , Middle Aged , Osteosarcoma/metabolism , Osteosarcoma/mortality , Receptor, Angiotensin, Type 1/chemistry , Receptor, Angiotensin, Type 1/genetics
11.
Cell Physiol Biochem ; 42(4): 1540-1549, 2017.
Article in English | MEDLINE | ID: mdl-28723693

ABSTRACT

BACKGROUND/AIMS: The injury and apoptotic cell death of endothelial cells hallmark the development of atherosclerosis (AS), characterized by dysregulation of lipid homeostasis, immune responses, and formation of coronary plaques. However, the mechanisms underlying the initiation of endothelial cell apoptosis remain ill-defined. Recent evidence suggests a role of microRNAs in the processes of AS-associated endothelial cell apoptosis. Thus, we studied this question in the current study. METHODS: AS was developed in ApoE (-/-) mice suppled with high-fat diet (HFD), compared to ApoE (-/-) mice suppled with normal diet (ND). Mouse endothelial cells were isolated from the aortic arch using flow cytometry based on their expression of Pecam-1. Oxidized low-density lipoprotein (ox-LDL) were used to treat human aortic endothelial cells (HAECs) as an in vitro model for AS. Gene expression was quantified by RT-qPCR and protein levels were analyzed by Western blotting. Apoptosis was evaluated by FITC Annexin V Apoptosis essay and by TUNEL staining. Prediction of the binding between miRNAs and 3'-UTR of mRNA from the target gene was performed by bioinformatics analyses and confirmed by a dual luciferase reporter assay. RESULTS: HFD mice, but not ND mice, developed AS in 12 weeks. Significantly reduced endothelial cell marks and significantly increased mesenchymal cell marks were detected in the aortic arch of the HFD mice, compared to the ND mice. The endothelial cell apoptosis was significantly higher in HFD mice, seemingly due to functional suppression of protein translation of anti-apoptotic Bcl-Xl protein through upregulation of miR-876. Similar results were obtained from in vitro study. Inhibition of miR-876 abolished the effects of ox-LDL-induced apoptotic cell death of HAECs. CONCLUSION: AS-associated endothelial cell apoptosis may partially result from downregulation of Bcl-Xl, through upregulation of miR-876 that binds and suppresses translation of Bcl-Xl mRNA.


Subject(s)
Aorta/metabolism , Atherosclerosis/genetics , Endothelial Cells/metabolism , Gene Expression Regulation , MicroRNAs/genetics , bcl-X Protein/genetics , Animals , Aorta/drug effects , Aorta/pathology , Apolipoproteins E/deficiency , Apolipoproteins E/genetics , Apoptosis/genetics , Atherosclerosis/etiology , Atherosclerosis/metabolism , Atherosclerosis/pathology , Binding Sites , Cell Line , Diet, High-Fat/adverse effects , Disease Models, Animal , Endothelial Cells/drug effects , Endothelial Cells/pathology , Humans , Lipoproteins, LDL/pharmacology , Mice , Mice, Knockout , MicroRNAs/antagonists & inhibitors , MicroRNAs/metabolism , Oligoribonucleotides, Antisense/genetics , Oligoribonucleotides, Antisense/metabolism , Platelet Endothelial Cell Adhesion Molecule-1/genetics , Platelet Endothelial Cell Adhesion Molecule-1/metabolism , Primary Cell Culture , Protein Biosynthesis , RNA, Messenger/genetics , RNA, Messenger/metabolism , Signal Transduction , bcl-X Protein/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...